This test product is classified as a Class II medical device. It is currently being developed for potential application in Endoscopic Mucosal Resection (EMR) and Endoscopic Submucosal Dissection (ESD). AceGel is designed to be injected under the mucosa of a lesion, where research focuses on its ability to create a separation layer between normal and diseased tissues, as well as to elevate the mucosa for procedural observation.

Research studies include early-stage gastric, esophageal, colorectal conditions and polyps, with evaluations conducted to analyze its potential role in clinical procedures.